New Obesity Pill Approved for Israel, Priced Around 1,000 Shekels
Translated & summarized from i24NEWS by baba
Israel will be the fourth country to approve Orforglipron, a new once-daily oral pill for obesity, available from September 15 and costing around 1,000 shekels monthly. The drug is absorbed through the digestive system and comes in six dosages.
The story in 4 lines · by baba
- New oral obesity pill Orforglipron approved in Israel.
- Available September 15, costing approximately 1,000 shekels.
- Israel is the fourth country to receive the drug.
- Taken once daily, absorbed without food dependency.
Israel is set to become the fourth country globally to approve a new oral medication for obesity, Orforglipron. The drug, which requires a once-daily pill intake, will be available in pharmacies starting September 15. This marks a significant development as it offers an alternative to injectable weight-loss treatments.
Orforglipron is a small molecule designed for absorption in the digestive system, independent of meal times or consumption of food or drink. It will be offered in six different dosages, providing flexibility for patient treatment plans. The submission for approval to the Ministry of Health and inclusion in the national health basket indicates a move towards wider accessibility.
The medication is expected to cost approximately 1,000 shekels per month. The approval signifies a growing trend in pharmaceutical innovation for weight management, with Israel being an early adopter of this new oral therapy.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 7Right 1Other 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.